dextrothyroxine has been researched along with Coronavirus Infections in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 34 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borges, P; Botton, MR; Freitas, M; Hentschke-Lopes, M; Mancuso, ACB; Matte, U | 1 |
| Chen, J; Cheng, Q; Fang, Z; Jia, Q; Zhao, G | 1 |
| Du, W; Duan, H; Fan, F; Huang, H; Li, D; Li, S; Li, Y; Qin, P; Wang, Y; Yang, X; Zhao, C | 1 |
| Caly, L; Catton, MG; Druce, JD; Jans, DA; Wagstaff, KM | 1 |
| Fabbrocini, G; Patrì, A | 1 |
| Şimşek Yavuz, S; Ünal, S | 1 |
| Chaccour, C; Hammann, F; Rabinovich, NR; Ramón-García, S | 1 |
| Bray, M; Jans, D; Noël, F; Rayner, C; Wagstaff, K | 1 |
| Tapia, L | 1 |
| Anastasiou, IA; Eleftheriadou, I; Tentolouris, A; Tentolouris, N; Tsilingiris, D | 1 |
| Hajlaoui, K; Karray, M; Litaiem, N; Slouma, M; Zeglaoui, F | 1 |
| Wamae, CN | 1 |
| Rizzo, E | 1 |
| Bonilla-Aldana, DK; Dhama, K; Leblebicioglu, H; Patel, SK; Pathak, M; Rodriguez-Morales, AJ; Sah, R; Sharun, K; Singh, BR; Tiwari, R | 1 |
| Azanza, JR; Brew, J; Carmona-Torre, F; Casellas, A; Chaccour, C; Dobaño, C; Fernández, M; Giráldez, M; Hammann, F; Moncunill, G; Mota, JS; Rabinovich, R; Reina, G; Richardson, MA; Ruiz-Castillo, P; Sadaba, B; Yuste, JR | 1 |
| Freeman, PR; Horowitz, RI | 1 |
| Ahmed, SN; Banerjee, K; Dalai, CK; Nandy, M | 1 |
| Burger, JA; de Castro, CG; Gregianin, LJ | 1 |
| Allouche, M; Alwasel, S; Beyrem, H; Boufahja, F; Essid, N; Harrath, AH; Lazzem, M; Mahmoudi, E; Mansour, L | 1 |
| Alonso, DF; Farina, HG | 1 |
| Arora, VK; Behera, D; Tripathy, SK; Vora, A | 1 |
| Cao, Y; Hanafin, PO; Jermain, B; Lanusse, C; Lifschitz, A; Rao, GG | 1 |
| Barroso, J; DiNicolantonio, JJ; McCarty, M | 1 |
| Jans, DA; Wagstaff, KM | 1 |
| Hasan, M; Hasan, MN; Hosen, MJ; Jaman, J; Karim, MA; Karim, Z; Parvez, MSA; Tahsin, T | 1 |
| Gupta, SP | 1 |
| Perišić, O | 1 |
| Abizanda, G; Aldaz, A; Casellas, A; Chaccour, C; Gil, AG; Hammann, F; Irigoyen-Barrio, Á; Martínez-Galán, F | 1 |
| Mega, ER | 1 |
| Almuedo-Riera, A; Camprubí, D; Grau-Pujol, B; Hurtado, JC; Krolewiecki, A; Martí-Soler, H; Muñoz, J; Soriano, A; Subirà, C | 1 |
| Mishra, SK; Tripathi, T | 1 |
| Arévalo, AP; Bollati-Fogolín, M; Crispo, M; Daghero, H; Duhalde Vega, M; Hill, M; Pagotto, R; Pórfido, JL; Segovia, M; Varela, B; Verdes, JM; Yamasaki, K | 1 |
| Holzgreve, H | 1 |
| Chow, VT; Chu, JJH; Tan, KSW; Tan, YL | 1 |
6 review(s) available for dextrothyroxine and Coronavirus Infections
| Article | Year |
|---|---|
Comparative efficacy and safety of pharmacological interventions for severe COVID-19 patients: An updated network meta-analysis of 48 randomized controlled trials.
Topics: Colchicine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Doxycycline; Humans; Imatinib Mesylate; Immunization, Passive; Immunoglobulins, Intravenous; Interferon beta-1b; Ivermectin; Lopinavir; Methylprednisolone; Network Meta-Analysis; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; Ritonavir | 2022 |
Antiviral treatment of COVID-19
Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Humans; Hydroxychloroquine; Ivermectin; Lopinavir; Nitro Compounds; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; SARS-CoV-2; Thiazoles | 2020 |
Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal?
Topics: Animals; Antiviral Agents; Betacoronavirus; Cell Line; Chlorocebus aethiops; Coronavirus Infections; COVID-19; Dengue; Dengue Virus; HIV Infections; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Ivermectin; Pandemics; Pneumonia, Viral; SARS-CoV-2; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2.
Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; COVID-19 Vaccines; Gene Expression; Host-Pathogen Interactions; Humans; Hydroxychloroquine; Immunization, Passive; Ivermectin; Models, Molecular; Niclosamide; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Protein Interaction Domains and Motifs; Protein Structure, Secondary; SARS-CoV-2; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Spike Glycoprotein, Coronavirus; Viral Vaccines | 2020 |
One year update on the COVID-19 pandemic: Where are we now?
Topics: Adenosine Monophosphate; Alanine; Amides; Animals; Antiviral Agents; Chloroquine; Clinical Trials as Topic; Coronavirus; Coronavirus Infections; COVID-19; COVID-19 Vaccines; Drug Combinations; Drug Repositioning; Glucocorticoids; Humans; Hydroxychloroquine; Indoles; Ivermectin; Lopinavir; Mutation; Pandemics; Phytotherapy; Plant Extracts; Pyrazines; Ritonavir; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Tinospora; Viral Zoonoses | 2021 |
Topics: Ancylostomatoidea; Animals; Coronavirus; Coronavirus Infections; Hookworm Infections; Humans; Ivermectin | 2021 |
1 trial(s) available for dextrothyroxine and Coronavirus Infections
| Article | Year |
|---|---|
The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol
Topics: Adolescent; Adult; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Evaluation Studies as Topic; Female; Humans; Ivermectin; Male; Middle Aged; Pandemics; Pilot Projects; Pneumonia, Viral; Randomized Controlled Trials as Topic; Risk Factors; SARS-CoV-2; Time Factors; Viral Load; Young Adult | 2020 |
27 other study(ies) available for dextrothyroxine and Coronavirus Infections
| Article | Year |
|---|---|
Sales of "COVID kit" drugs and adverse drug reactions reported by the Brazilian Health Regulatory Agency.
Topics: Azithromycin; Brazil; Coronavirus Infections; COVID-19 Drug Treatment; Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxychloroquine; Ivermectin; Pandemics; Pneumonia, Viral | 2022 |
Evaluating anti-viral effect of Ivermectin on porcine epidemic diarrhea virus and analyzing the related genes and signaling pathway by RNA-seq in vitro.
Topics: Animals; Antiviral Agents; Chlorocebus aethiops; Coronavirus Infections; Ivermectin; Porcine epidemic diarrhea virus; RNA-Seq; Signal Transduction; Swine; Swine Diseases; Vero Cells | 2023 |
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.
Topics: Animals; Antiviral Agents; Australia; Betacoronavirus; Chlorocebus aethiops; Coronavirus Infections; COVID-19; Drug Approval; Humans; Ivermectin; Pandemics; Pneumonia, Viral; SARS-CoV-2; Vero Cells; Virus Replication | 2020 |
Hydroxychloroquine and ivermectin: A synergistic combination for COVID-19 chemoprophylaxis and treatment?
Topics: Betacoronavirus; Chemoprevention; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Ivermectin; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Ivermectin and COVID-19: Keeping Rigor in Times of Urgency.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Ivermectin; Pandemics; Pneumonia, Viral; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus | 2020 |
Ivermectin and COVID-19: A report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses.
Topics: Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Ivermectin; Pandemics; Pneumonia, Viral; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus | 2020 |
COVID-19 and Fake News in the Dominican Republic.
Topics: Antibodies, Monoclonal, Humanized; Antiviral Agents; Azithromycin; Betacoronavirus; Civil Disorders; Coronavirus Infections; COVID-19; Dissent and Disputes; Dominican Republic; Drug Repositioning; Humans; Hydroxychloroquine; Ivermectin; Pandemics; Pneumonia, Viral; Politics; Public Health; SARS-CoV-2; Social Media; Trust | 2020 |
In Vitro Data of Current Therapies for SARS-CoV-2.
Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; China; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Emetine; Homoharringtonine; Humans; Hydroxychloroquine; Ivermectin; Lopinavir; Nitro Compounds; Pandemics; Pneumonia, Viral; SARS-CoV-2; Teicoplanin; Thiazoles | 2020 |
Acute generalized exanthematous pustulosis after COVID-19 treatment with hydroxychloroquine.
Topics: Acute Generalized Exanthematous Pustulosis; Betacoronavirus; Chemoprevention; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Ivermectin; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Mass Drug Administration and Worms Experience in Africa: Envisage Repurposing Ivermectin for SARS-COV-2.
Topics: Africa; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Humans; Ivermectin; Onchocerciasis, Ocular; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Ivermectin, antiviral properties and COVID-19: a possible new mechanism of action.
Topics: Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Ivermectin; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Ivermectin; Pandemics; Pneumonia, Viral; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus | 2020 |
Three novel prevention, diagnostic, and treatment options for COVID-19 urgently necessitating controlled randomized trials.
Topics: Acetazolamide; Anti-Inflammatory Agents; Anticoagulants; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Diet Therapy; Humans; Immune System; Inflammation; Ivermectin; Mass Screening; NF-E2-Related Factor 2; NF-kappa B; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; Resource Allocation; Risk; Sildenafil Citrate; Treatment Outcome | 2020 |
The Battle against COVID 19 Pandemic: What we Need to Know Before we "Test Fire" Ivermectin.
Topics: Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Disease Models, Animal; Humans; Ivermectin; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Drug Repositioning; Humans; Ivermectin; Leukemia, Myeloid, Acute; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Ecotoxic response of nematodes to ivermectin, a potential anti-COVID-19 drug treatment.
Topics: Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; France; Humans; Italy; Ivermectin; Mediterranean Sea; Nematoda; Pandemics; Pneumonia, Viral; SARS-CoV-2; Spain | 2020 |
Repurposing of host-based therapeutic agents for the treatment of coronavirus disease 2019 (COVID-19): a link between antiviral and anticancer mechanisms?
Topics: Anticholesteremic Agents; Antineoplastic Agents; Antiparasitic Agents; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Administration Schedule; Drug Repositioning; Host-Pathogen Interactions; Humans; Hypoglycemic Agents; Ivermectin; Lovastatin; Metformin; Nitro Compounds; Pandemics; Pneumonia, Viral; SARS-CoV-2; Severity of Illness Index; Thiazoles | 2020 |
White paper on Ivermectin as a potential therapy for COVID-19.
Topics: Antiparasitic Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Ivermectin; Pandemics; Pneumonia, Viral; Risk Factors; SARS-CoV-2; Treatment Outcome | 2020 |
Development of a Minimal Physiologically-Based Pharmacokinetic Model to Simulate Lung Exposure in Humans Following Oral Administration of Ivermectin for COVID-19 Drug Repurposing.
Topics: Administration, Oral; Animals; Antiviral Agents; Betacoronavirus; Cattle; Computer Simulation; Coronavirus Infections; COVID-19; Drug Repositioning; Humans; Ivermectin; Lung; Models, Biological; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19.
Topics: Animals; Anti-Inflammatory Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drugs, Essential; Host-Pathogen Interactions; Humans; Ivermectin; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome | 2020 |
Prediction of potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-2 using comprehensive drug repurposing and molecular docking approach.
Topics: Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Fidaxomicin; Humans; Ivermectin; Molecular Docking Simulation; Pandemics; Pneumonia, Viral; Rifabutin; Rifampin; RNA-Dependent RNA Polymerase; SARS-CoV-2; Virus Replication | 2020 |
Recognition of Potential COVID-19 Drug Treatments through the Study of Existing Protein-Drug and Protein-Protein Structures: An Analysis of Kinetically Active Residues.
Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antibodies, Viral; Antigen-Antibody Reactions; Antiviral Agents; Betacoronavirus; Binding Sites; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Eflornithine; Humans; Hydrophobic and Hydrophilic Interactions; Ivermectin; L-Lactate Dehydrogenase; Models, Molecular; Molecular Docking Simulation; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Proline; Protein Binding; Protein Conformation; Protein Interaction Mapping; Receptors, Glycine; Saposins; SARS-CoV-2; Sofosbuvir; Spike Glycoprotein, Coronavirus; Structure-Activity Relationship | 2020 |
Nebulized ivermectin for COVID-19 and other respiratory diseases, a proof of concept, dose-ranging study in rats.
Topics: Administration, Inhalation; Animals; Antiparasitic Agents; Behavior, Animal; Coronavirus Infections; COVID-19; Dose-Response Relationship, Drug; Female; Half-Life; Ivermectin; Lung; Male; Necrosis; Pandemics; Pneumonia, Viral; Proof of Concept Study; Rats; Rats, Sprague-Dawley; Respiration Disorders | 2020 |
Latin America's embrace of an unproven COVID treatment is hindering drug trials.
Topics: Animals; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Evidence-Based Medicine; Humans; Ivermectin; Latin America; Pandemics; Pneumonia, Viral; Reproducibility of Results; Retraction of Publication as Topic | 2020 |
Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients.
Topics: Adult; Antibodies, Monoclonal, Humanized; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Female; Humans; Immunosuppressive Agents; Ivermectin; Male; Middle Aged; Nasopharynx; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2; Treatment Outcome | 2020 |
Ivermectin reduces in vivo coronavirus infection in a mouse experimental model.
Topics: Animals; Antiviral Agents; Body Weight; Coronavirus Infections; Disease Models, Animal; Female; Ivermectin; Kidney; Liver; Mice, Inbred BALB C; Monocytes; Murine hepatitis virus; Neutrophils; Proteins; Transaminases; Tumor Necrosis Factor-alpha; Viral Load | 2021 |
Combination Treatment With Remdesivir and Ivermectin Exerts Highly Synergistic and Potent Antiviral Activity Against Murine Coronavirus Infection.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Coronavirus Infections; COVID-19 Drug Treatment; Humans; Ivermectin; Mice; Murine hepatitis virus; Pandemics; SARS-CoV-2 | 2021 |